Relationship between HLA-C locus and restenosis after coronary artery balloon angioplasty

Y Watanabe1, N Yamada, H Yokoi

  • 1Department of Cardiology, Juntendo University, Japan.

JAMA
|March 26, 1997
PubMed

Insights

Human leukocyte antigen (HLA) typing, specifically HLA-Cw1, may predict restenosis after percutaneous transluminal coronary angioplasty (PTCA). This finding could aid in identifying patients at higher risk for the condition.

Area of Science:

  • Immunogenetics
  • Cardiovascular Medicine

Background:

  • Restenosis is a significant complication following percutaneous transluminal coronary angioplasty (PTCA).
  • Human leukocyte antigen (HLA) genes play a crucial role in immune responses and have been implicated in various cardiovascular conditions.

Purpose of the Study:

  • To investigate the association between specific human leukocyte antigen (HLA) loci and the occurrence of restenosis after PTCA.
  • To identify potential HLA-based biomarkers for predicting restenosis risk.

Main Methods:

  • A cross-sectional study was conducted involving 65 patients who underwent PTCA.
  • Patients were selected consecutively between October 1994 and June 1995 at Juntendo University Hospital.
  • Human leukocyte antigen (HLA) typing was performed to analyze genetic associations.

Main Results:

  • A significant negative relationship was observed between HLA-Cw1 and restenosis after PTCA.
  • The multivariate adjusted odds ratio for restenosis associated with HLA-Cw1 was 0.19 (95% CI, 0.06-0.63; P=.007).

Conclusions:

  • HLA-Cw1 may serve as a valuable predictive marker for restenosis in patients undergoing PTCA.
  • Further research into HLA typing could enhance risk stratification and personalized treatment strategies for post-PTCA restenosis.
Abstract

Related Concept Videos